Welcome to our dedicated page for National Grid SEC filings (Ticker: NGG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
National Grid’s cross-Atlantic operations make its disclosures unusually dense; one annual report 10-K must reconcile UK price-control frameworks with U.S. rate-base math. If you have searched for storm-cost recovery details or tried to track executive stock sales across subsidiaries, you know the challenge.
Stock Titan solves that problem with AI-powered summaries that turn multi-jurisdiction documents into clear takeaways. The platform delivers real-time alerts the moment a National Grid insider trading Form 4 transaction or an 8-K hits EDGAR, then highlights what matters—allowed returns, capital-expenditure guidance, or renewable-integration costs. Key filings are mapped to specific questions investors ask:
- 10-K / 20-F – “National Grid annual report 10-K simplified” shows regulated earnings drivers and debt-ahead-of-rate case schedules.
- 10-Q – “National Grid quarterly earnings report 10-Q filing” surfaces segment margins and weather impacts.
- 8-K – “National Grid 8-K material events explained” flags rate-case rulings or storm-related cost deferrals.
- Form 4 – “National Grid executive stock transactions Form 4” gives context to insider moves, complete with trend charts.
- DEF 14A – “National Grid proxy statement executive compensation” outlines incentive structures tied to grid-modernization metrics.
Whether you’re comparing cap-ex across periods, monitoring “National Grid Form 4 insider transactions real-time,” or simply understanding National Grid SEC documents with AI, Stock Titan delivers concise, actionable insights. Stop scrolling through PDFs and focus instead on rate-base growth, dividend safety, and emerging-grid investment—information our AI distills from every National Grid earnings report filing analysis.
National Grid plc (NGG) has filed a Form 6-K disclosing Ofgem’s Draft Determination for the RIIO-ET3 price-control period covering April 2026–March 2031. The draft relates to National Grid Electricity Transmission (NGET) and follows the company’s final business plan submission in December 2024. Ofgem continues to acknowledge the need for "significant levels of investment" in the UK transmission network and has proposed allowance decisions for a subset of projects; the remainder will be assessed through in-period mechanisms.
National Grid reiterates its intention to deploy around £60 billion of group-wide capital expenditure between now and March 2029, underscoring the scale of network expansion required to meet rising electrification and decarbonisation targets. Management will scrutinise the draft package to determine whether it offers an "investable" financial framework, highlighting that further progress on incentive mechanisms is still required to balance consumer value with shareholder returns.
The company will engage with Ofgem through the consultation phase leading to a Final Determination expected in December 2025. Securing an attractive allowed return, incentive upside and timely cost recovery will be critical to funding the planned investments while preserving credit metrics and dividend capacity. The filing contains extensive forward-looking-statement disclaimers but no new earnings guidance.
HUTCHMED (China) Limited filed a Form 6-K for June 2025 containing three exhibits.
- Exhibit 99.3: Announces Chinese regulatory approval for ORPATHYS® in combination with TAGRISSO® to treat lung-cancer patients with MET amplification who have progressed after first-line EGFR inhibitor therapy. This represents a new therapeutic option and the only materially substantive development in the filing.
- Exhibit 99.1: A block-listing six-monthly return, an administrative Hong Kong Stock Exchange requirement detailing potential share issuances under existing schemes.
- Exhibit 99.2: Disclosure of the company’s current total voting rights, providing an updated share count for investors.
The approval disclosed in Exhibit 99.3 could meaningfully expand HUTCHMED’s oncology portfolio and addressable patient base in mainland China, whereas Exhibits 99.1 and 99.2 are routine corporate housekeeping items with no immediate financial metrics or transactions reported.
FAQ
What is the current stock price of National Grid (NGG)?
What is the market cap of National Grid (NGG)?
What is the core business of National Grid?
How does National Grid generate its revenue?
Which regions are served by National Grid?
What is National Grid doing to modernize its infrastructure?
How does National Grid support economic growth in its service areas?
What measures does National Grid implement for operational risk management?
How is National Grid positioned in terms of technological innovation?
In what ways does National Grid engage with the local community?
